Association between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis

Association between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis

Abstract Background Anti-angiogenesis treatments are the most commonly used treatments for the vision loss caused by exudative age-related macular degeneration (AMD), in which the anti-vascular endothelial growth factor (VEGF) drugs with ranibizumab and bevacizumab are current standard treatments. H...

Full description

Bibliographic Details
Main Authors: Ya-li Zhou, Chun-li Chen, Yi-xiao Wang, Yao Tong, Xiao-ling Fang, Lin Li, Zhao-yang Wang
Format: Article
Language:English
Published: BMC 2017-06-01
Series:BMC Ophthalmology
Subjects:
Anti-VEGF
Exudative AMD
HTRA1 gene
Treatment response
Online Access:http://link.springer.com/article/10.1186/s12886-017-0487-2

Internet

http://link.springer.com/article/10.1186/s12886-017-0487-2

Similar Items